IL160109A0 - Topical pharmaceutical formulation - Google Patents

Topical pharmaceutical formulation

Info

Publication number
IL160109A0
IL160109A0 IL16010902A IL16010902A IL160109A0 IL 160109 A0 IL160109 A0 IL 160109A0 IL 16010902 A IL16010902 A IL 16010902A IL 16010902 A IL16010902 A IL 16010902A IL 160109 A0 IL160109 A0 IL 160109A0
Authority
IL
Israel
Prior art keywords
pharmaceutical formulation
topical pharmaceutical
admixture
composition
active agent
Prior art date
Application number
IL16010902A
Other languages
English (en)
Original Assignee
Advanced Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Biotechnologies filed Critical Advanced Biotechnologies
Publication of IL160109A0 publication Critical patent/IL160109A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16010902A 2001-07-24 2002-07-23 Topical pharmaceutical formulation IL160109A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30754801P 2001-07-24 2001-07-24
PCT/GB2002/003387 WO2003009877A1 (en) 2001-07-24 2002-07-23 Topical pharmaceutical formulation

Publications (1)

Publication Number Publication Date
IL160109A0 true IL160109A0 (en) 2004-06-20

Family

ID=23190223

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16010902A IL160109A0 (en) 2001-07-24 2002-07-23 Topical pharmaceutical formulation
IL160109A IL160109A (en) 2001-07-24 2004-01-28 Medication for topical treatment

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160109A IL160109A (en) 2001-07-24 2004-01-28 Medication for topical treatment

Country Status (21)

Country Link
US (1) US8263114B2 (xx)
EP (1) EP1409034B1 (xx)
JP (1) JP3778559B2 (xx)
KR (1) KR101009267B1 (xx)
CN (1) CN1234426C (xx)
AT (1) ATE331537T1 (xx)
AU (1) AU2002317981B2 (xx)
BR (1) BRPI0211282B8 (xx)
CA (1) CA2454673C (xx)
DE (1) DE60212847T2 (xx)
DK (1) DK1409034T3 (xx)
ES (1) ES2268061T3 (xx)
HK (1) HK1061362A1 (xx)
IL (2) IL160109A0 (xx)
MX (1) MXPA04000444A (xx)
NO (1) NO334175B1 (xx)
NZ (1) NZ529957A (xx)
PT (1) PT1409034E (xx)
RU (1) RU2306121C2 (xx)
WO (1) WO2003009877A1 (xx)
ZA (1) ZA200400488B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070237834A1 (en) * 2003-04-18 2007-10-11 Bioderm Research Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
AU2004253749B2 (en) * 2003-07-03 2010-04-01 The University Court Of The University Of St Andrews Zeolites for delivery of nitric oxide
MX2007005476A (es) * 2004-11-07 2008-04-22 Cupron Corp Materiales que contienen cobre para tratar heridas, quemaduras y otras condiciones de la piel.
WO2007085086A1 (en) * 2006-01-30 2007-08-02 Sanjeev Kaila A composition including a silicone-based polymer and a method of treating skin disorders using the composition
EP2168407B1 (en) * 2007-06-29 2013-10-23 Carmanah Technologies Corp. Intelligent area lighting system
UA28103U (uk) * 2007-07-12 2007-11-26 Ольга Олександрівна Біляєва Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
GB0821345D0 (en) * 2008-11-21 2008-12-31 P Q Silicas Uk Ltd Composition and dressing with nitric oxide
WO2010079209A2 (en) * 2009-01-08 2010-07-15 Golub Alexandr A Compositions for treating wounds and skin conditions
US20100322875A1 (en) * 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
CA2765393A1 (en) * 2009-07-17 2011-01-20 Carefusion 2200, Inc. Particles incorporating antimicrobial agents
RU2429820C2 (ru) * 2009-09-24 2011-09-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН") Антисептическая мазь наружного применения (2 варианта)
JP5877790B2 (ja) * 2009-11-03 2016-03-08 リピドール エービー 生体の表面に投与するための脂質層形成性組成物
AU2010316006B2 (en) * 2009-11-03 2013-09-26 Lipidor Ab Composition for promoting wound healing
US10500173B2 (en) * 2010-06-17 2019-12-10 Covalon Technologies Inc. Antimicrobial silicone-based wound dressings
WO2012150890A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Antibacterial composition
US20130144225A1 (en) 2011-12-06 2013-06-06 Jessica Rowen Method And Device For Scar Management
TWI474823B (zh) * 2013-09-25 2015-03-01 Far Eastern New Century Corp 疤痕凝膠的組成物
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106729963A (zh) * 2016-12-22 2017-05-31 苏州迈达医疗器械有限公司 一种硅酮凝胶敷料及其生产工艺
US10496949B2 (en) 2017-01-04 2019-12-03 Christopher Zoumalan Compositions and methods for treating cutaneous conditions
RU2674445C1 (ru) * 2017-12-11 2018-12-10 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Спрей для наружного применения спиртовой
CN108714141A (zh) * 2018-05-29 2018-10-30 南京华开生物科技有限公司 硅酮疤痕喷剂
WO2020019050A1 (en) * 2018-07-26 2020-01-30 Exciton Pharma Corp. Vehicles and delivery systems for oxidizing agents
WO2020061671A1 (en) * 2018-09-26 2020-04-02 Exaltexx Inc. Winterized maturing agent, viscosity reducer and production enhancer
US11433016B2 (en) 2019-03-28 2022-09-06 L'oreal Cosmetic compositions for skin
US11207255B2 (en) 2019-07-30 2021-12-28 L'oreal Perfluoro-free self-foaming facial cleanser composition
US11364190B2 (en) 2019-07-30 2022-06-21 L'oreal Acid perfluoro-free self-foaming facial cleanser composition
US11213473B1 (en) 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0618899B2 (ja) * 1987-06-30 1994-03-16 品川燃料株式会社 抗菌性ゼオライト含有フィルム
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
JPH049327A (ja) 1990-04-04 1992-01-14 Kootec Kk 創傷被覆材
FR2678513B1 (fr) * 1991-07-03 1995-06-30 Laboratoires Hygiene Dietetique Pansement cicatrisant.
EP0848621B1 (en) 1995-07-19 2003-03-26 Advanced Medical Solutions Limited Wound treatment composition
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
JPH09194350A (ja) 1996-01-19 1997-07-29 Morishita Jintan Kk 創傷被覆材
US6231259B1 (en) * 1996-07-26 2001-05-15 The Gillette Company Viscous product dispenser with porous dome
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
AU1923199A (en) * 1997-12-17 1999-07-05 Hemodynamics, Inc. Sealing media for surgery and wound closure
MXPA01008160A (es) 1999-02-12 2002-04-24 Procter & Gamble Composiciones desinfectantes de la piel.
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
GB0007140D0 (en) * 1999-09-27 2000-05-17 Dow Corning Sa Scar treatment composition
MXPA02011440A (es) 2000-05-23 2003-04-25 Unilever Nv Composiciones desodorantes y/o antitranspirantes.
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
JP5449173B2 (ja) * 2007-09-30 2014-03-19 バレアント ファーマシューティカルズ インターナショナル 創傷治癒および瘢痕減少のためのシリコーンゲルに基づく組成物

Also Published As

Publication number Publication date
US20040234474A1 (en) 2004-11-25
BR0211282A (pt) 2004-08-03
MXPA04000444A (es) 2004-10-27
RU2004105164A (ru) 2005-06-27
CA2454673A1 (en) 2003-02-06
KR20040032864A (ko) 2004-04-17
US8263114B2 (en) 2012-09-11
CN1527729A (zh) 2004-09-08
PT1409034E (pt) 2006-11-30
EP1409034B1 (en) 2006-06-28
HK1061362A1 (en) 2004-09-17
NO334175B1 (no) 2014-01-06
DK1409034T3 (da) 2006-10-30
JP2005502639A (ja) 2005-01-27
KR101009267B1 (ko) 2011-01-18
BR0211282B1 (pt) 2018-01-09
DE60212847D1 (de) 2006-08-10
ES2268061T3 (es) 2007-03-16
RU2306121C2 (ru) 2007-09-20
JP3778559B2 (ja) 2006-05-24
NO20040319L (no) 2004-01-23
AU2002317981B2 (en) 2006-12-07
EP1409034A1 (en) 2004-04-21
ZA200400488B (en) 2005-06-29
IL160109A (en) 2008-04-13
ATE331537T1 (de) 2006-07-15
DE60212847T2 (de) 2007-06-14
NZ529957A (en) 2005-11-25
BRPI0211282B8 (pt) 2021-05-25
CA2454673C (en) 2011-04-26
CN1234426C (zh) 2006-01-04
WO2003009877A1 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
HK1061362A1 (en) Topical pharmaceutical formulation
AU3539001A (en) Chip that comprises an active agent and an integrated heating element
AU2002343191A1 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
IL159584A0 (en) Pharmaceutical formulation comprising a proton pump inhibitor and antacids
IL152339A0 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
BR0107869A (pt) Composições farmacêuticas eletrogiradas
HUP0301163A3 (en) 7-substituted tetracycline dervatives, pharmaceutical compositions containing them and their use
AU2002349705A1 (en) Azole compound and medicinal use thereof
HUP0301452A3 (en) Pharmaceutical composition containing photochemotherapeutic agent and mucoadhesive agent and its use
HK1076755A1 (en) Wound dressing
HUP0300720A3 (en) Serine protease inhibitors, pharmaceutical compositions containing them and their use
IL157741A0 (en) Pharmaceutical compositions containing an antihyperplastic active agent
IL159591A0 (en) Pharmaceutical compositions containing terbinafin and use thereof
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
HK1054192A1 (en) Kahalalide formulation
HK1063469A1 (en) N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans
HUP0300128A3 (en) Male contraceptive composition comprising norethisterone and its use
AU2001232113A1 (en) Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
AU2001295301A1 (en) Medicinal composition and in particular its use in fluid therapy
AU2002302684A1 (en) Film-forming composition for topical use and use thereof for delivering active agents
AU2002328929A1 (en) Medicament formulation for topical application in the therapy and prophylaxis of hyperhidrosis
AU2002216404A1 (en) Medicinal compositions containing diuretic and insulin resistance-improving agent
AU2002326460A1 (en) Hydroxyl-terminated polybutadienes and their use in curing formulations
IL161691A0 (en) Plasminogen activating factor and pharmaceutical compositions containing the same
AU2002234655A1 (en) Disinfectant and preservative formulation and applications thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed